Safety Study for Refractory or Relapsed Neuroblastoma With DFMO Alone and in Combination With Etoposide
This study is ongoing, but not recruiting participants.
Cancer Prevention Pharmaceuticals, Inc.
University of Arizona
University of Hawaii
Information provided by (Responsible Party):
Giselle Sholler, Van Andel Research Institute
First received: January 26, 2010
Last updated: February 12, 2013
Last verified: February 2013
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study is ongoing, but not recruiting participants.|
|Estimated Study Completion Date:||June 2016|
|Estimated Primary Completion Date:||June 2013 (Final data collection date for primary outcome measure)|